主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
P
PILL
Direxion Daily Pharmaceutical & Medical Bull 3X Shares
12.4
3
USD
-1.19%
版块:
金融
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-1.19%
每月变动
+5.07%
6个月变化
+10.69%
年变化
+147.61%
前一天收盘价
12.5
8
Open
12.4
3
最低价
12.4
3
High
12.4
3
交易量
1
市场
US ETFs
PILL
展开完整图表
完整图表
概览
所有持仓
热图
主要持股
Market Value
Shares
Weight %
GOLDMAN FINANCIAL
4.2 M
4.2 M
23.6%
GOLDMAN SACHS LIQ ES FD A
870.0 K
870.0 K
4.9%
DREYFUS GOVERNMENT CASH MANAGE
799.1 K
799.1 K
4.5%
DFTX
Definium Therapeutics Inc.
349.4 K
20.7 K
1.9%
LQDA
Liquidia Corporation
332.4 K
7 842.0
1.9%
MBX
MBX Biosciences, Inc.
327.7 K
8 892.0
1.8%
AXSM
Axsome Therapeutics Inc.
316.4 K
1 717.0
1.8%
OGN
Organon & Co
304.8 K
35.7 K
1.7%
EWTX
Edgewise Therapeutics Inc.
303.9 K
10.8 K
1.7%
ELAN
Elanco Animal Health Inc
289.7 K
12.0 K
1.6%
MRK
Merck & Co., Inc
289.3 K
2 624.0
1.6%
VTRS
Viatris Inc
289.1 K
22.1 K
1.6%
AMRX
Amneal Pharmaceuticals Inc
287.1 K
21.0 K
1.6%
JNJ
Johnson & Johnson
281.8 K
1 240.0
1.6%
RPRX
Royalty Pharma PLC
279.3 K
6 700.0
1.6%
AMLX
Amylyx Pharmaceuticals Inc
276.8 K
19.4 K
1.5%
BMY
Bristol-Myers Squibb Company
275.5 K
5 005.0
1.5%
XERS
Xeris Biopharma Holdings Inc
271.7 K
36.9 K
1.5%
ZTS
Zoetis Inc.
271.0 K
2 171.0
1.5%
PRGO
Perrigo Company PLC
269.3 K
19.0 K
1.5%
1
2
3
4
新闻
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
Defensive Stocks: A Potential Antidote To Inflation Shocks
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies